|
市場調查報告書
亞洲醫療設備市場
Asian Medical Device Markets
|
亞洲醫療設備市場 是由出版商Kalorama Information在2007年05月所出版的。
這份英文市場調查報告書包含260 pages 價格從美金1995起跳。
Abstract
Although Asia Pacific was the smallest healthcare market as of 2006, out of
the three major geographic regions (US, Europe, and Asia Pacific), continued
growth makes it an important ancillary market for makers of medical devices.
Kalorama Information' s Asian Medical Device Markets is your guide to the
market for medical devices in 5 key markets:
- Australia
- Japan
- South Korea
- China
- India
What countries are the best targets for growth in Asia and why? How are Asian
markets structured and what regulations do new entrants need to know? What
companies have been successful marketing devices in Asia? This report answers
these questions and includes:
- Historical & Current Revenues for Medical Devices in 5 markets.
- Forecasted Market Size to 2010.
- Complete Demand-Side Analysis takes into account purchasing
entities and important drivers for growth.
- Extensive Background on Asian Healthcare Spending.
- Key Regulations that will impact Asian device markets and
Certifications necessary to compete in this market.
- Detailed Profiles of companies operating in the Asian Device market.
- Seven Solid Conclusions serious market-watchers will need to know.
Information is derived from extensive research of company reports, medical
literature, trade publications and government data. But as part of Kalorama' s
trusted information-gathering process, industry experts are interviewed for
their assessment of the market.
Product Managers, Marketing Directors, Business Development Executives in
device companies, as well as advertising and financial executives serving or
investing in medical device companies are among those who will benefit from
this report.
Table of Contents
Chapter One: Executive Summary
- 1.1 Healthcare Industry
- 1.2 Healthcare In Asia
- 1.3 Definition And Scope
- 1.4 Medical Devices
- 1.5 Market Overview
- 1.5.1 Japan
- 1.5.2 China
- 1.5.3 Australia
- 1.5.4 South Korea
- 1.5.5 India
- 1.6 Demand Side Analysis
- 1.6.1 Japan
- 1.6.2 China
- 1.6.3 Australia
- 1.6.4 South Korea
- 1.6.5 India2
- 1.7 Key Regulations And Certifications
- 1.7.1 Japan
- 1.7.2 China
- 1.7.3 Australia
- 1.7.4 South Korea
- 1.7.5 India
- 1.8 Conclusions
Chapter Two: Introduction
- 2.1 Healthcare Industry
- 2.1.1 Worldwide Healthcare Market
- 2.2 Healthcare in Asia
- 2.2.1 Asia - Healthcare Statistics
- 2.2.1.1 Healthcare Spending as a Percentage of GDP
- 2.2.1.2 Per Capita Healthcare Spending
- 2.2.2 Trends in Asian Healthcare Markets
- 2.3 Definition and Scope
- 2.3.1 Definition
- 2.3.2 Geographical Scope of the Study
Chapter three: Classification of Medical Devices
- 3.1 Definition
- 3.2 Classification of Medical Devices
- 3.3 Categorization of Medical Devices
Chapter four: Market Data & Analysis
- 4.1 Australia
- 4.1.1 Market Size
- 4.1.2 Market Size Projections
- 4.1.3 Industry Structure
- 4.1.4 Trends
- 4.1.4.1 Import-Export Trends
- 4.1.4.2 Australian Medical Devices - Worldwide Acceptance
- 4.1.4.3 Medical Devices vs Pharmaceutical Products - Development Cycle
- 4.1.5 Factors Affecting the Market
- 4.1.5.1 Growth Drivers
- 4.1.5.2 Growth Inhibitors
- 4.2 China
- 4.2.1 Market Size
- Taiwan Market
- 4.2.2 Market Size Projections
- 4.2.3 Trends
- 4.2.4 Factors Affecting the Market
- 4.2.4.1 Growth Drivers
- 4.2.4.2 Growth Inhibitors
- 4.3 India
- 4.3.1 Market Size
- 4.3.2 Market Size Projections
- 4.3.3 Trends
- 4.3.3.1 Import-Export Trends
- 4.3.3.2 Medical Tourism
- 4.3.4 Factors Affecting the Market
- 4.3.4.1 Growth Drivers
- 4.4 Japan
- 4.4.1 Market Size
- 4.4.2 Market Size Projections
- 4.4.3 Industry Structure
- 4.4.3.1 Business through General Dealers
- 4.4.3.2 Business through Specialist Dealers
- 4.4.3.3 Direct Sales
- 4.4.4 Trends
- 4.4.4.1 Import-Export Trends
- 4.4.4.2 Eldercare Market
- 4.4.5 Factors Affecting the Market
- 4.4.5.1 Growth Drivers
- 4.4.5.2 Growth Inhibitors
- 4.5 South Korea
- 4.5.1 Market Size
- 4.5.2 Market Size Projections
- 4.5.3 Trends
- 4.5.3.1 Import-Export Trends
- 4.5.4 Factors Affecting the Market
- 4.5.4.1 Growth Drivers
- 4.5.4.2 Growth Inhibitors
Chapter Five: Demand Side Analysis
- 5.1 Australia
- 5.1.1 Demand Side Statistics
- 5.1.1.1 Increase in the Number of Hospitals and Related Expenditure
- 5.1.1.2 Statistics Related to Medical Procedures
- 5.1.2 Demographics
- 5.1.2.1 Increase in the Number of People Aged 65 Years and Above
- 5.2 China
- 5.2.1 Potential Market for Replacement Sales
- 5.2.2 Higher Demand for Medical Devices from ' Retirement Homes'
- 5.2.3 Demand for High-Quality Medical Devices and More Efficient
Healthcare Services
- 5.2.4 Increased Acceptance of Diagnostic Devices in Taiwan
- 5.3 India
- 5.3.1 Public Sector vs Private Sector
- 5.3.2 Healthcare Infrastructure
- 5.3.2.1 Government Healthcare Infrastructure
- 5.3.2.2 Private Healthcare Infrastructure
- 5.3.3 Demographics
- 5.3.3.1 Increase in the Number of People Aged 65 Years and Above
- 5.4 Japan
- 5.4.1 Demographics
- 5.4.1.1 Increase in the Number of People Aged 65 Years and Above
- 5.4.2 Medical Devices Preferences
- 5.5 South Korea
- 5.5.1 Modernization of Hospitals
- 5.5.2 Increasing Demand for Homecare Medical Devices
Chapter Six: Key Regulations and Certifications
- 6.1 Global Regulatory Bodies
- 6.1.1 Global Harmonization Task Force (GHTF)
- 6.1.2 US Food and Drug Administration (US FDA)
- 6.2 Australia
- 6.2.1 Regulatory Bodies and Committees
- 6.2.1.1 Therapeutic Goods Administration (TGA)
- 6.2.1.2 The Australian Register of Therapeutic Goods (ARTG)
- 6.3 China
- 6.3.1 Key Regulations
- 6.3.2 Regulations and Registrations in Taiwan
- 6.3.3 Recent Regulatory Changes
- 6.3.3.1 Medical Devices Testing
- 6.3.3.2 New Pricing Policy for Medical Devices
- 6.3.3.3 New Regulation - Medical Devices Quality System Management
- 6.3.3.4 Registration
- 6.3.3.5 Supervising Medical Devices Manufacturers
- 6.4 India
- 6.4.1 Regulatory Bodies and Committees
- 6.4.1.1 Indian Medical Devices Regulatory Authority
- 6.4.1.2 Central Drug Standard Control Organization (CDSCO)
- 6.5 Japan
- 6.5.1 Regulations
- 6.5.1.1 Revision of Medical Devices Approval Applications
Classifications
- 6.5.2 Certifications
- 6.5.2.1 MHLW Ministerial Ordinance No. 169, 2004
- 6.5.2.2 MHLW Ministerial Ordinance No. 2, 1961, revised by MHLW
Ministerial Ordinance No. 73, 2005
- 6.5.2.3 MHLW Ministerial Ordinance No. 136, 2004
- 6.6 South Korea
- 6.6.1 Key Regulations
- 6.6.2 Registrations for Medical Devices Approval
- 6.6.2.1 Classification of Medical Devices
- 6.6.2.2 Manufacturing/Importing Approval/Announcement Application
- 6.6.2.3 Examination of Technical Documents
- 6.6.2.4 Testing
- 6.6.2.5 Medical Devices Manufacture/Import and Quality Control Rules
Chapter Seven: Conclusions
- 7.1 First Conclusion
- 7.2 Second Conclusion
- 7.3 Third Conclusion
- 7.4 Fourth Conclusion
- 7.5 Fifth Conclusion
- 7.6 Sixth Conclusion
- 7.7 Seventh Conclusion
Chapter Eight: Company Profiles
- 8.1 3M Company
- 8.1.1 Key Facts
- 8.1.2 Company Overview
- 8.1.3 Geographical Presence and Subsidiaries
- 8.1.4 Product Portfolio
- 8.1.5 Key Executives
- 8.1.6 Performance Review
- 8.1.6.1 Revenue Performance
- 8.1.6.2 Performance of Business Segments
- 8.1.6.3 Performance of Geographic Segments
- 8.1.6.4 Performance of the Healthcare Segment
- 8.1.7 Company Strategy
- 8.2 B Braun Melsungen Ag (B. Braun)
- 8.2.1 Key Facts
- 8.2.2 Company Overview
- 8.2.3 Product Portfolio
- 8.2.4 Key Executives
- 8.2.5 Key Competitors
- 8.2.6 Performance Review
- 8.2.6.1 Revenue Performance
- 8.2.6.2 Performance of Business Segments
- 8.2.6.3 Performance of Geographic Segments
- 8.3 Beijing Wandong Medical Equipment Co., Ltd
- 8.3.1 Key Facts
- 8.3.2 Company Overview
- 8.3.3 Geographical Presence and Business Lines
- 8.3.4 Product Portfolio
- 8.3.5 Key Executives
- 8.3.6 Key Competitors
- 8.3.7 Performance Review
- 8.3.7.1 Revenue Performance
- 8.3.7.2 Performance of Business Segments
- 8.3.7.3 Performance of Geographic Segments
- 8.3.8 Company Strategy
- 8.4 Cochlear Limited
- 8.4.1 Key Facts
- 8.4.2 Company Overview
- 8.4.3 Geographical Presence and Subsidiaries
- 8.4.4 Product Portfolio
- 8.4.4.1 Nucleus Freedom Cochlear Implant System
- 8.4.4.2 Baha System
- 8.4.5 Key Executives
- 8.4.6 Performance Review
- 8.4.6.1 Revenue Performance
- 8.4.7 Company Strategy
- 8.5 GE Healthcare Company
- 8.5.1 Key Facts
- 8.5.2 Company Overview
- 8.5.3 Geographical Presence and Business Lines
- 8.5.4 Product Portfolio
- 8.5.5 Staff Organization
- 8.5.7 Key Competitors
- 8.5.8 Performance Review
- 8.5.8.1 Revenue Performance
- 8.5.8.2 Performance of Business Segments
- 8.5.9 Company Strategy
- 8.6 Hitachi Medical Corporation
- 8.6.1 Key Facts
- 8.6.2 Company Overview
- 8.6.3 Geographical Presence and Business Lines
- 8.6.4 Product Portfolio
- 8.6.5 Organization of Business
- 8.6.6 Key Executives
- 8.6.7 Key Competitors
- 8.6.8 Performance Review
- 8.6.8.1 Revenue Performance
- 8.6.8.2 Performance of Business Segments
- 8.6.8.3 Performance of Geographic Segments
- 8.7 Johnson & Johnson Co., Ltd
- 8.7.1 Key Facts
- 8.7.2 Company Overview
- 8.7.3 Geographical Presence and Business Lines
- 8.7.4 Product Portfolio
- 8.7.5 Staff Organization
- 8.7.6 Key Executives
- 8.7.7 Key Competitors
- 8.7.8 Performance Review
- 8.7.8.1 Revenue Performance
- 8.7.8.2 Performance of Business Segments
- 8.7.8.3 Performance of Geographic Segments
- 8.7.9 Company Strategy
- 8.8 Medison Co., Ltd
- 8.8.1 Key Facts
- 8.8.2 Company Overview
- 8.8.3 Geographical Presence and Business Lines
- 8.8.4 Product Portfolio
- 8.8.5 Staff Organization
- 8.8.5.1 Marketing Services
- 8.8.5.2 Research and Development Services
- 8.8.5.3 Production Services
- 8.8.5.4 Administration Services
- 8.8.6 Key Executives
- 8.8.7 Key Competitors
- 8.8.8 Performance Review
- 8.8.8.1 Revenue Performance
- 8.8.8.2 Performance of Business Segments
- 8.8.9 Company Strategy
- 8.9 Philips Medical Systems Technologies Ltd
- 8.9.1 Key Facts
- 8.9.2 Company Overview
- 8.9.3 Geographic Presence
- 8.9.4 Product Portfolio
- 8.9.6 Key Competitors
- 8.9.7 Performance Review
- 8.9.7.1 Revenue Performance
- 8.9.7.2 Performance of Geographic Segments
- 8.9.8 Company Strategy
- 8.10 ResMed, Inc.
- 8.10.1 Key Facts
- 8.10.2 Company Overview
- 8.10.4 Product Portfolio
- 8.10.5 Key Executives
- 8.10.6 Performance Review
- 8.10.6.1 Revenue Performance
- 8.10.6.2 Performance of Geographic Segments
- 8.10.7 Company Strategy
- 8.10.7.1 Core Growth Strategies
- 8.10.7.2 Strategic Acquisitions
- 8.10.7.3 Global Sales and Marketing
- 8.10.9.4 Collaboration with Associations
- 8.11 Siemens Medical Solutions
- 8.11.1 Key Facts
- 8.11.2 Company Overview
- 8.11.3 Geographical Presence and Business Lines
- 8.11.4 Product Portfolio
- 8.11.5 Key Executives
- 8.11.6 Key Competitors
- 8.11.7 Performance Review
- 8.11.7.1 Revenue Performance
- 8.12 Terumo Corporation
- 8.12.1 Key Facts
- 8.12.2 Company Overview
- 8.12.3 Geographical Presence and Business Lines
- 8.12.4 Product Portfolio
- 8.12.5 Key Executives
- 8.12.6 Key Competitors
- 8.12.7 Performance Review
- 8.12.7.1 Revenue Performance
- 8.12.7.2 Performance of Business Segments
- 8.12.7.3 Performance of Geographic Segments
- 8.12.8 Company Strategy
- 8.13 Toshiba Medical Systems Corporation
- 8.13.1 Key Facts
- 8.13.2 Company Overview
- 8.13.3 Geographical Presence and Business Lines
- 8.13.4 Product Portfolio
- 8.13.5 Organization of Business
- 8.13.6 Key Executives
- 8.13.7 Key Competitors
- 8.13.8 Performance Review
- 8.13.8.1 Revenue Performance
- 8.13.8.2 Performance of Business Segments
- 8.13.8.3 Performance of Geographic Segments
LIST OF EXHIBITS
Chapter One: Executive Summary
- Figure 1-1: Expenditure on Healthcare as a Percentage of GDP - Asia
(2005-2006)
- Figure 1-2: Medical Device Categories
- Figure 1-3: Asian Medical Device Markets (Australia, China, India, Japan,
South Korea), 2006-2010
Chapter two: Introduction
- Figure 2-1: Value Chain of the Healthcare Industry
- Table 2-1: World Population Predictions 2005 and 2050
- Figure 2-2: Healthcare Spending as a Percentage of GDP - Asia (2005-2010)
- Figure 2-3: Per Capita Healthcare Spending - Asia (2005-2010)
- Figure 2-4: Total Healthcare Expenditure Break-up for Asia Pacific (2005)
- Figure 2-5: Expenditure on Healthcare as a Percentage of GDP - Asia
(2005-2006)
- Figure 2-6: Per Capita Healthcare Spending - Asia (2005-2006)
Chapter three: Classification of Medical Devices
- Figure 3-1: Medical Device Classification
- Figure 3-2: Medical Device Categories
- Figure 3-3: Classification of Surgical Equipment
Chapter four: Market Data & Analysis
- Table 4-1: Asian Medical Device Market, 5 Key Countries (Australia, China,
India, Japan, South Korea) 2007-2010
- Figure 4-1: Australian Medical Device market Size (2003-2005)
- Figure 4-2: Australian Medical Device Market Size - Projection (2007-2010)
- Figure 4-3: Australian Medical Device market - Segmentation
(Diagnostic/Imaging Equipment, Ophthalmic Equipment, Others), 2006
- Figure 4-4: Australian Medical Device Industry Structure
- Figure 4-5: Australia - Domestic Production (2004)
- Figure 4-6: Australia - Domestic Consumption (2004)
- Figure 4-7: Medical Devices vs Pharmaceutical Products - Development Cycle
- Figure 4-8: Aging Population - Australia (Age Group 65 Years and above)
- Figure 4-9: Public Sector vs Private Sector Purchase of Medical Devices -
Australia (2005)
- Figure 4-10: Chinese Medical Device market Size (2000-2006)
- Figure 4-11: Production Value of Medical Devices in Taiwan (2002-2006)
- Figure 4-12: Chinese Medical Device market Size - Projection (2005-2010)
- Figure 4-13: Chinese Medical Device market - Segmentation (IV Diagnostics
Equipment, Disposable Equipment, Ophthalmic Equipment, Others) , 2006 (in USD
million) Figure 4-14: Indian Medical Device market Size (1993, 2005-2006)
- Figure 4-15: Indian Medical Device market Size - Projection (2007-2010)
- Figure 4-16: Indian Medical Device market - Segmentation (Diagnostic
Equipment, Imaging Equipment, Others)�
- Figure 4-17: India - Domestic Consumption (2004)
- Figure 4-18: Medical Tourism Industry in India (2006-2012)
- Figure 4-19: Japanese Medical Device market Size (2000-2006)
- Figure 4-20: Japanese Medical Device market Size - Projection (2006-2010)
- Figure 4-21: Japanese Medical Device market - Segmentation (IV Diagnostic
Equipment, Disposable Equipment, Ophthalmic Equipment, Others), 2006
- Figure 4-22: Distribution Patterns for Medical Devices in Japan
- Figure 4-23: Import and Export of Japanese Medical Devices as a Percent of
Market Output (1997-2007)
- Table 4-2: Population Needing Home Treatment - Forecast (1993-2025)
- Table 4-3: Average Age of Japan' s Population (1990-2005)
- Figure 4-24: South Korean Medical Device market Size (2000-2006)
- Figure 4-25: Medical Devices Manufacturing Market (2000-2006)
- Figure 4-26: Medical Devices Manufacturing Companies' Market Share (2004)
- Figure 4-27: South Korea Medical Device market Size - Projection
(2007-2010)
- Figure 4-28: South Korean Medical Device market - Segmentation (Disposable
and Non-Disposable Equipment, 2006
- Figure 4-29: South Korea Medical Devices Imports (2000-2010)
Chapter Five: Demand Side Analysis
- Figure 5-1: Public Sector vs Private Sector - Purchase of Medical Devices
(2006)
- Table 5-1: Number of Hospitals (2000-2001 to 2004-2005)
- Figure 5-2: Number of Public Hospitals vs Private Hospitals - Australia
(2005)
- Table 5-2: Total Recurrent Expenditure from 2000-2001 to 2004-2005
- Table 5-3: Statistics for Public Hospitals - by Procedure (2004-2005)
- Table 5-4: Procedure Statistics for Private Hospitals - by Procedure
(2004-2005)
- Figure 5-3: Aging Population - Australia (Age Group of 65 Years and Above)
- Figure 5-4: Supply-Demand Gap in China' s Medical Device market (2003-2008)
- Figure 5-5: Healthcare Industry - Public Sector vs Private Sector (2006)
- Table 5-5: Healthcare Infrastructure in India (2004)
- Table 5-6: Size of Private Hospitals - Healthcare Units (2004)
- Table 5-7: Demographics Forecast (2010-2050).
- Table 5-8: Aging Demographics Forecast (2000-2050)
Chapter Six: Key Regulations and Certifications
- Figure 6-1: Australian Medical Devices Legislation - Features
- Figure 6-2: Australian Medical Devices - Route to Market
- Figure 6-3: Drug and Cosmetics Act - Implementation Framework - Central
and State Drug Administrations (CDA)
- Figure 6-4: Structure of Central Drug Standard Control Organization
- Table 6-1: Approval, Licensing, and Notification System - Pharmaceutical
Affairs Law
Chapter Seven: Conclusions
- Figure 7-1: Asian Medical Device Markets - Market Attractiveness Chart
Chapter Eight: Company Profiles
- Table 8-1: Corporate Details of 3M
- Table 8-2: Geographical Presence and Subsidiaries of 3M
- Table 8-3: Key Executives of 3M
- Figure 8-1: 3M Revenue Performance (2001-2006)
- Figure 8-2: 3M Revenues (by Business Segment) (2006)
- Figure 8-3: 3M Revenues (by Geography) (2006)
- Figure 8-4: 3M Revenues (Healthcare Segment) (2004-2006)
- Table 8-4: Corporate Details of B. Braun
- Table 8-5: Product Portfolio of B. Braun
- Table 8-6: Key Executives of B. Braun
- Figure 8-5: B. Braun Revenue Performance (2004-2005)
- Figure 8-6: B. Braun Revenues (by Business Segment) (2005)
- Figure 8-7: B. Braun Revenues (by Geography) (2005)
- Table 8-7: Corporate Details of Beijing Wandong Medical Equipment
- Table 8-8: Major Branches and Business Lines of Wandong Medical
- Table 8-9: Key Executives of Wandong Medical
- Figure 8-8: Wandong Medical Revenue Performance (2001-2005)
- Figure 8-9: Wandong Medical Revenues (by Business Segment) (2005)
- Figure 8-10: Wandong Medical Revenues (by Geography) (2005)
- Table 8-10: Corporate Details of Cochlear Limited
- Table 8-11: Geographical Presence and Subsidiaries of Cochlear
- Table 8-12: Key Executives of Cochlear
- Figure 8-11: Cochlear Revenue Performance (2001-2006)
- Figure 8-12: Cochlear Revenues (by Geography) (2006)
- Figure 8-13: Cochlear Revenue Performance (by Geography) (2004-2006)
- Table 8-13: Corporate Details of GE Healthcare
- Table 8-14: Major (Asia Pacific) Operating Locations and Business Lines of
GE Healthcare
- Table 8-15: Key Executives of GE Healthcare
- Figure 8-14: GE Healthcare Revenue Performance (2002-2006)
- Figure 8-15: GE Revenues (by Business Segment) (2006)
- Figure 8-16: GE Income (by Business Segment) (2006)
- Table 8-16: Corporate Details of Hitachi Medical Corporation
- Table 8-17: Geographical Presence and Business Lines of Hitachi Medical
Corporation
- Table 8-18: Key Executives of Hitachi Medical Corporation
- Figure 8-17: Hitachi Medical Corporation Revenue Performance (2004-2006)
- Figure 8-18: Hitachi Medical Revenue Performance (by Business Segment)
(2006)
- Figure 8-19: Hitachi Medical Revenue Performance (by Geography) (20006)
- Table 8-19: Corporate Details of Johnson & Johnson
- Table 8-20: Major Locations and Business Lines of Johnson & Johnson in
Asia Pacific
- Table 8-21: Key Executives of Johnson & Johnson
- Figure 8-20: Johnson & Johnson Revenue Performance (2002-2006)
- Figure 8-21: Johnson & Johnson Revenues (by Business Segment) (2006)
- Figure 8-22: Johnson & Johnson Revenues (by Geography) (2006)
- Figure 8-23: Medical Devices and Diagnostics Segment Revenues (by
Geography) (2006)
- Table 8-22: Corporate Details of Medison
- Table 8-23: Geographical Presence and Business Lines of Medison
- Table 8-24: Key Executives of Medison
- Figure 8-24: Medison Revenue Performance (2002-2005)
- Figure 8-25: Medison Revenues (by Geography) (2005)
- Table 8-25: Corporate Details of Philips Medical Systems Technologies Ltd
- Table 8-26: Presence of Philips Medical Systems in Asia Pacific
- Table 8-27: Key Executives of Philips Medical Systems
- Figure 8-26: Philips Medical Systems Revenue Performance (2002-2006)
- Figure 8-27: Philips Medical Systems Revenues (by Geography) (2002-2006)
- Table 8-28: Corporate Details of ResMed, Inc.
- Table 8-29: Geographical Presence of ResMed
- Table 8-30: Product Portfolio of ResMed
- Table 8-31: Key Executives of ResMed
- Figure 8-28: ResMed Revenue Performance (2002-2006)
- Figure 8-29: ResMed Revenues (by Geography) (2006)
- Table 8-32: Acquisitions of ResMed (1996-2005)
- Table 8-33: Corporate Details of Siemens Medical Solutions
- Table 8-34: Geographical Presence and Business Lines of Siemens Medical
Solutions
- Table 8-35: Key Executives of Siemens Medical Solutions
- Figure 8-30: Siemens Medical Solutions Revenue Performance (2002-2006)
- Table 8-36: Corporate Details of Terumo Corporation
- Table 8-37: Geographical Presence and Business Lines of Terumo Corporation
- Table 8-38: Key Executives of Terumo
- Figure 8-31: Terumo Corporation Revenue Performance (2004-2006)
- Figure 8-32: Terumo Corporation Revenues (by Business Segment) (2006)
- Figure 8-33: Terumo Corporation Revenues (by Geography) (2006)
- Table 8-39: Corporate Details of Toshiba Medical Systems Corporation
- Table 8-40: Geographical Presence and Business Lines of Toshiba Medical
Systems Corporation
- Figure 8-34: Business Divisions of Toshiba Corporation
- Table 8-41: Key Executives of Toshiba Corporation
- Figure 8-35: Toshiba Revenue Performance (by Business Segment) (2005)
- Figure 8-36: Toshiba Revenue Performance (by Geography) (2005)
|
